Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy
- 1 June 2010
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 70 (15), 1622-1627
- https://doi.org/10.1002/pros.21197
Abstract
BACKGROUND Genetic polymorphism located within the IL16 gene has been reported to be associated with aggressive prostate cancer (PCa). Our aim was to establish whether the tissue expression of IL16 is a prognostic factor of survival in PCa. METHODS The files of patients who underwent radical prostatectomy (RP) between 1995 and 2001 were reviewed. The cases were selected and classified according to the D'Amico classification for risk of recurrence (intermediate or high). The value of IL16 and its receptor CCR5 (chemokine (C-C motif) receptor 5) expression levels were determined as witness of aggressiveness patterns and markers of biological relapse in patients with PCa treated by RP. A tissue microarray of 304 cases was constructed. IL16 and CCR5 expression levels were characterized by immunohistochemistry. RESULTS IL16 expression was correlated with high Gleason score (i.e., >7) (P < 0.01). It was not significant for CCR5. IL16 and CCR5 were not associated with prostate-specific antigen (PSA) or capsular extension of the disease. The accurate prediction of disease outcome, using stratification of cases, according to negative margins and D'Amico classification was significantly enhanced by status of IL16 expression (P ≤ 0.01). In univariate analyses, Gleason score, PSA level, stage and loss of IL16 expression were related to better biological-free survival (P < 0.05) but not CCR5. In a multivariate analysis, IL16 expression, Gleason score, and tumor stage were independent factors for biochemical-free survival (P = 0.001). CONCLUSIONS IL16 appears to be a useful prognostic factor in PCa. Its expression in PCa tissue was correlated to tumor aggressiveness and biochemical relapse of the disease. Prostate 70: 1622–1627, 2010.Keywords
This publication has 25 references indexed in Scilit:
- The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancerCarcinogenesis: Integrative Cancer Research, 2008
- Effect of Genetic Variability within 8q24 on Aggressiveness Patterns at Diagnosis and Familial Status of Prostate CancerClinical Cancer Research, 2008
- Multiple loci identified in a genome-wide association study of prostate cancerNature Genetics, 2008
- Inflammation in prostate carcinogenesisNature Reviews Cancer, 2007
- Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumorsArchivum Immunologiae et Therapiae Experimentalis, 2007
- Postoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical ProstatectomyJournal of Clinical Oncology, 2005
- Radical Prostatectomy versus Watchful Waiting in Early Prostate CancerThe New England Journal of Medicine, 2005
- Impact of the Percentage of Positive Prostate Cores on Prostate Cancer–Specific Mortality for Patients With Low or Favorable Intermediate-Risk DiseaseJournal of Clinical Oncology, 2004
- DNA microarray analysis of the gene expression profiles of naı̈ve versus activated tumor-specific T cellsLife Sciences, 2002
- Cancer — Nature, Nurture, or BothThe New England Journal of Medicine, 2000